Clinical Trials Browser

Phase 2 × Chondrosarcoma × drozitumab × Clear all

NCT00543712 2022-12-13

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Phase 2 Terminated

Chondrosarcoma, Sarcoma, Sarcoma, Synovial